Tilray Brands shows an extreme risk/reward skew with 117% analyst upside and a passed asymmetry gate, but quality below the engine's floor, a confirmed downtrend with a death-cross block, and high short interest keep the engine's recommendation at exit.
Thesis pillars
- Quality Below Floor Value Trap→Stable
- High Asymmetry Large Analyst Upside→Stable
- Failed Momentum Confirmed Downtrend→Stable
- +1 more pillar — see the Why tab for full reasoning
Tilray Brands, Inc. (TLRY) Stock Analysis
Inst Constrain edge
Healthcare · Drug Manufacturers - Specialty & Generic
Sell if holding. Engine safety override at $4.38: Quality below floor (2.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10 and A.R:R 8.4:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 15%; Below-average business quality; Below long-term trend.
Tilray Brands operates four segments — beverage, cannabis, distribution, and wellness — cultivating and selling medical and adult-use cannabis in Canada and Europe while producing craft beer and spirits brands including SweetWater and Breckenridge in the United States. The... Read more
Sell if holding. Engine safety override at $4.38: Quality below floor (2.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10 and A.R:R 8.4:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 15%; Below-average business quality; Below long-term trend. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.4/10, moderate confidence.
Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 21d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.
About Tilray Brands, Inc.
About Tilray Brands, Inc.
Tilray Brands generated $821.3 million in total net revenue during fiscal 2025 across four reportable segments — distribution (33%), cannabis (30%), beverage (29%), and wellness (8%) — with cannabis operations concentrated in Canada and medical cannabis exports reaching patients in more than 20 countries. The company's craft beverage brands, including SweetWater and Breckenridge, make it the fourth-largest craft brewer in the United States.
Tilray's cannabis business depends on licenses issued by Health Canada under the Cannabis Regulations to cultivate, process, and export medical and adult-use cannabis, with EU-GMP certified facilities in Portugal and Germany supporting international medical cannabis sales. The beverage segment sells its craft beers, ciders, and spirits — including SweetWater, Breckenridge, and Montauk — through independent distributors across the United States, while the distribution segment purchases and resells pharmaceutical and wellness products and the wellness segment markets Manitoba Harvest hemp-based foods. The company competes against numerous licensed cannabis producers in Canada, which Health Canada has authorized in the thousands, as well as established beverage companies and illicit-market cannabis suppliers that operate without regulatory compliance costs.
Show full overview
A pending U.S. regulatory shift dominates Tilray's forward risk profile: cannabis meeting the federal definition of marijuana remains a Schedule I controlled substance under the Controlled Substances Act, even as rescheduling to Schedule III remains under consideration and the 2018 Farm Bill's hemp exemption for products under 0.3% THC content faces potential FDA rulemaking. The 10-K notes Health Canada has issued approximately a thousand licenses to Licensed Producers, intensifying domestic competition, while Tilray's U.S. activity stays limited to corporate services, clinical-trial drug supply, and Farm-Bill-compliant hemp products pending any federal legalization.
See also: Healthcare · Drug Manufacturers - Specialty & Generic
From Tilray Brands, Inc.'s most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-07-08Recent Developments — Tilray Brands, Inc.
Latest news
- NEWS Tilray Brands To Acquire HelloMD Corporation; Financial Terms Not Disclosed — benzinga Jun 29, 2026 positive
Generated 2026-07-08T21:03:53Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers·1 ceiling hit
Unprofitable operations — net margin -156.7%. Quality floor flags this regardless of sector context.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $4.38: Quality below floor (2.3 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10 and A.R:R 8.4:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 15%; Below-average business quality; Below long-term trend. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $4.08. Score 5.4/10, moderate confidence.
Take-profit target: $8.42 (+92.0% upside). Prior stop was $4.08. Stop-loss: $4.08.
Quality below floor (2.3 < 4.0).
Tilray Brands, Inc. trades at a P/E of N/A (forward 16.2). TrendMatrix value score: 9.3/10. Verdict: Sell.
17 analysts cover TLRY with a consensus score of 3.6/5. Average price target: $10.
What does Tilray Brands, Inc. do?Tilray Brands operates four segments — beverage, cannabis, distribution, and wellness — cultivating and selling medical...
Tilray Brands operates four segments — beverage, cannabis, distribution, and wellness — cultivating and selling medical and adult-use cannabis in Canada and Europe while producing craft beer and spirits brands including SweetWater and Breckenridge in the United States. The company generated $821.3 million in total net revenue in fiscal 2025, with distribution (33%), cannabis (30%), beverage (29%), and wellness (8%) each contributing meaningfully.